Cipla has been developing respiratory medicines for patients for more than 40 years and we are the second largest global manufacturer of respiratory inhalers, committed to becoming a global leader in respiratory care. We have a range of high-quality respiratory products, designed with similar instructions and features to the market-leading originator brands. At Cipla, we have priced our range to be more sustainable and affordable so more NHS patients can receive optimal care. We are dedicated to minimising our environmental footprint in support of the NHS goal of becoming carbon net zero by 2040.

CIPCOR20240038 October 2024